We started with one constraint: protect any medication with nothing added.

In 2017, TrueMed faced a unique challenge that would ultimately shape their trajectory. A pulp and paper company, teetering due to rampant counterfeiting, sought their expertise. This marked the genesis of their journey towards pioneering AI solutions.

Harnessing their AI prowess, TrueMed crafted an innovative platform capable of detecting counterfeits with unparalleled precision. The remarkable twist? This AI relied solely on images snapped by mobile phones, a breakthrough in itself.

Then, a pivotal moment occurred during a staff member’s illness abroad. Desperate for relief, he bought medication from a local pharmacy. What he couldn’t verify was the medicine’s authenticity – a concerning revelation.

Combining their AI proficiency with this newfound perspective, TrueMed saw a broader canvas. Their technology, initially for paper, transcended to healthcare, specifically counterfeit drug detection.

Pharmaceutical companies became the next destination. Conversations revealed a pervasive issue: counterfeit medications endangering lives. Stirred by the urgency, TrueMed took it upon themselves to be part of the solution.

Thus, TrueMed was born – a nexus where cutting-edge AI met the imperative of global health. Armed with their technology, they endeavored to reshape pharmaceuticals by eradicating counterfeits, safeguarding families and communities worldwide.

The journey, ignited by a paper company’s distress, culminated in a mission that held integrity at its core. TrueMed’s saga echoes the power of innovation and purpose, proving that an unexpected challenge can set the stage for profound transformation.